glutathione and hemochromatosis Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver | Hepatology International The Surprising Cancer Risk in
Description
Due to the drugs abuse potential, the drug was classified as a Schedule I controlled substance in 2000, before the FDA found some medicinal use in the drug for narcolepsy treatment, making it a Schedule III drug
[DOI] [PMC free article] [PubMed] [Google Scholar] 75.Ono K, Han J
References Nguyen, H
Conclusion Accurate identification is essential for early diagnosis of hospital-acquired infections and administration of the proper antimicrobial treatment
